Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells.
about
Multifunction hexagonal liquid-crystal containing modified surface TiO2 nanoparticles and terpinen-4-ol for controlled release.hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.New photosensitizers for photodynamic therapyTargeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studiesGeneration and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging
P2860
Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@en
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@nl
type
label
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@en
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@nl
prefLabel
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@en
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@nl
P2093
P2860
P1476
Development of novel anti-Kv 1 ...... c ductal adenocarcinoma cells.
@en
P2093
Angelica Sette
Annarosa Arcangeli
Bernard Haye
Jolanda Spadavecchia
Olivia Crociani
Sandra Casale
P2860
P2888
P356
10.1007/S11051-013-2111-6
P577
2013-11-16T00:00:00Z